Nurith Aizenman
-
There's a looming debt crisis in many lower income countries. Low interest rates a few years back started the cycle. Then came a series of once in a generation shocks. Is there a solution? -
Botswana has one of the last thriving elephant herds – and a history of human-elephant conflict that threatens both sides. A nonprofit has a program to shift that dynamic. Will it work?
-
The World Health Organization registry holds 11 million data points — key to addressing global health inequality. Yet health officials stress how much information is still missing.
-
Dr. Daniel Bausch says of his work, "You realize that's all on the response side." He's come to appreciate that "the impact is with trying to change the system."
-
Tuberculosis kills 1.6 million a year — the second deadliest infectious disease after COVID-19. Using immune cells and mRNA technology, scientists in South Africa are working on a new vaccine.
-
That's the view of Joseph Glauber of the International Food Policy Research Institute. He considers the fear the war would lead to a surge in food prices – and a dramatic worsening of world hunger.
-
The South African-based scientist who co-discovered the omicron variant of COVID-19 makes an intriguing argument.
-
Afrigen is the linchpin of global project to use mRNA technology to empower low-resource countries to make their own vaccines against killer diseases from TB to HIV. What will it take to succeed?
-
Dr. Gabriela Kucharski's city of Toledo had virtually no vaccines. And it's a bastion of support for Brazil's vaccine skeptic president. Here's why that didn't matter.
-
Can we end poverty, provide food for all and otherwise make Earth a better place by 2030? By all accounts, the answer is no. So then what's the point of the Sustainable Development Goals?
